The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Special Article
PreviousPrevious
Volume 329:326-331 July 29, 1993 Number 5
NextNext

The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer
John Z. Ayanian, Betsy A. Kohler, Toshi Abe, and Arnold M. Epstein

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Women without private health insurance are less likely than privately insured women to be screened for breast cancer, and their treatment may differ after cancer is diagnosed. In this study we addressed two related questions: Do uninsured patients and those covered by Medicaid have more advanced breast cancer than privately insured patients when the disease is initially diagnosed? And, for each stage of disease, do uninsured patients and patients covered by Medicaid die sooner after breast cancer is diagnosed than privately insured patients?

Methods we studied 4675 women, 35 to 64 years of age, in whom invasive breast cancer was diagnosed from 1985 through 1987, by linking New Jersey State Cancer Registry records to hospital-discharge data. We compared the stage of disease and stage-specific survival among women with private insurance, no insurance, and Medicaid coverage through June 1992. We also estimated the adjusted risk of death for these groups, using proportional-hazards regression analysis to control for age, race, marital status, household income, coexisting diagnoses, and disease stage.

Results Uninsured patients and those covered by Medicaid presented with more advanced disease than did privately insured patients (P<0.001 and P = 0.01, respectively). Survival was worse for uninsured patients and those with Medicaid coverage than for privately insured patients with local disease (P<0.001 for both comparisons) and regional disease (P<0.001 for both comparisons), but not distant metastases. The adjusted risk of death was 49 percent higher (95 percent confidence interval, 20 to 84 percent) for uninsured patients and 40 percent higher (95 percent confidence interval, 4 to 89 percent) for Medicaid patients than for privately insured patients during the 54 to 89 months after diagnosis.

Conclusions The more frequent adverse outcomes of breast cancer among women without private health insurance suggest that such women would benefit from improved access to screening and optimal therapy.


Source Information

From the Division of General Medicine, Section on Health Services and Policy Research, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.Z.A., A.M.E.); the Department of Health Care Policy, Harvard Medical School, Boston (J.Z.A., A.M.E.); and the State Cancer Registry, New Jersey Department of Health, Trenton (B.A.K., T.A.).

Address reprint requests to Dr. Ayanian at the Department of Health Care Policy, Harvard Medical School, 25 Shattuck St., Parcel B, 1st Fl., Boston, MA 02115.

Full Text of this Article


Related Letters:

Health Insurance Coverage and Clinical Outcomes in Women with Breast Cancer
Hamilton V., Benk V., Fortin P., Ayanian J. Z., Kohler B. A., Epstein A. M.
Extract | Full Text  
N Engl J Med 1993; 329:2039-2040, Dec 30, 1993. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.